Related references
Note: Only part of the references are listed.Learning Induces Transient Upregulation of Brevican in the Auditory Cortex during Consolidation of Long-Term Memories
Hartmut Niekisch et al.
JOURNAL OF NEUROSCIENCE (2019)
Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status
Sebastian Palmqvist et al.
JAMA NEUROLOGY (2019)
National Institute on Aging - Alzheimer's Association Research Framework lays the groundwork for deeper understanding of Alzheimer's disease
David S. Knopman et al.
ALZHEIMERS & DEMENTIA (2018)
Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Melanie D. Sweeney et al.
NATURE REVIEWS NEUROLOGY (2018)
CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
Shorena Janelidze et al.
NEUROLOGY (2018)
Urokinase-type Plasminogen Activator (uPA) Binding to the uPA Receptor (uPAR) Promotes Axonal Regeneration in the Central Nervous System
Paola Merino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
Rebecca Sims et al.
NATURE GENETICS (2017)
Caspase-8, association with Alzheimer's Disease and functional analysis of rare variants
Jan Rehker et al.
PLOS ONE (2017)
Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity
Sebastian Palmqvist et al.
NATURE COMMUNICATIONS (2017)
A blood-based biomarker panel indicates IL-10 and IL-12/23p40 are jointly associated as predictors of β-amyloid load in an AD cohort
Steve Pedrini et al.
SCIENTIFIC REPORTS (2017)
Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid β
Elizabeth C. Mormino et al.
ALZHEIMERS & DEMENTIA (2017)
Dysregulation of lipids in Alzheimer's disease and their role as potential biomarkers
Matthew W. Wong et al.
ALZHEIMERS & DEMENTIA (2017)
A Review of Fluid Biomarkers for Alzheimer's Disease: Moving from CSF to Blood
Kaj Blennow
NEUROLOGY AND THERAPY (2017)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
Increased amyloidogenic APP processing in APOE ε4-negative individuals with cerebral β-amyloidosis
Niklas Mattsson et al.
NATURE COMMUNICATIONS (2016)
A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology
R. W. Paterson et al.
TRANSLATIONAL PSYCHIATRY (2016)
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
Shorena Janelidze et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease
Shorena Janelidze et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP
Vijay K. Ramanan et al.
BRAIN (2015)
Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes
Ester Canto et al.
BRAIN (2015)
Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings
Clifford R. Jack et al.
BRAIN (2015)
Amyloid β Oligomers Disrupt Blood-CSF Barrier Integrity by Activating Matrix Metalloproteinases
Marjana Brkic et al.
JOURNAL OF NEUROSCIENCE (2015)
Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease
Daniel Alcolea et al.
NEUROBIOLOGY OF AGING (2015)
Advanced glycation end products are mitogenic signals and trigger cell cycle reentry of neurons in Alzheimer's disease brain
Angela Kuhla et al.
NEUROBIOLOGY OF AGING (2015)
The anti-inflammatory glycoprotein, CD200, restores neurogenesis and enhances amyloid phagocytosis in a mouse model of Alzheimer's disease
Megan M. Varnum et al.
NEUROBIOLOGY OF AGING (2015)
Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease
Daniel Alcolea et al.
NEUROLOGY (2015)
Targeting caspase-6 and caspase-8 to promote neuronal survival following ischemic stroke
A. P. Shabanzadeh et al.
CELL DEATH & DISEASE (2015)
Plasma proteins predict conversion to dementia from prodromal disease
Abdul Hye et al.
ALZHEIMERS & DEMENTIA (2014)
A rare mutation in UNC5C predisposes to late-onset Alzheimer's disease and increases neuronal cell death
Monica K. Wetzel-Smith et al.
NATURE MEDICINE (2014)
Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
David Cook et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Tissue plasminogen activator arrests Alzheimer's disease pathogenesis
Shin Bi Oh et al.
NEUROBIOLOGY OF AGING (2014)
Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability
Erika Assarsson et al.
PLOS ONE (2014)
OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice
Munehisa Shimamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42 A Cross-Validation Study Against Amyloid Positron Emission Tomography
Sebastian Palmqvist et al.
JAMA NEUROLOGY (2014)
SPARC Regulates Microgliosis and Functional Recovery following Cortical Ischemia
Samantha M. Lloyd-Burton et al.
JOURNAL OF NEUROSCIENCE (2013)
Genetic Susceptibility for Alzheimer Disease Neuritic Plaque Pathology
Joshua M. Shulman et al.
JAMA NEUROLOGY (2013)
Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease
James D. Doecke et al.
ARCHIVES OF NEUROLOGY (2012)
CSF biomarkers for Alzheimer disease correlate with cortical brain biopsy findings
T. T. Seppala et al.
NEUROLOGY (2012)
Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease
M. Watabe-Rudolph et al.
NEUROLOGY (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
CX3CR1 Protein Signaling Modulates Microglial Activation and Protects against Plaque-independent Cognitive Deficits in a Mouse Model of Alzheimer Disease
Seo-Hyun Cho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The BMP Coreceptor RGMb Promotes While the Endogenous BMP Antagonist Noggin Reduces Neurite Outgrowth and Peripheral Nerve Regeneration by Modulating BMP Signaling
Chi H. E. Ma et al.
JOURNAL OF NEUROSCIENCE (2011)
Advanced glycation end product level, diabetes, and accelerated cognitive aging
K. Yaffe et al.
NEUROLOGY (2011)
Cerebrospinal Fluid Microglial Markers in Alzheimer's Disease: Elevated Chitotriosidase Activity but Lack of Diagnostic Utility
Niklas Mattsson et al.
NEUROMOLECULAR MEDICINE (2011)
A Blood-Based Screening Tool for Alzheimer's Disease That Spans Serum and Plasma: Findings from TARC and ADNI
Sid E. O'Bryant et al.
PLOS ONE (2011)
YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
Rebecca Craig-Schapiro et al.
BIOLOGICAL PSYCHIATRY (2010)
A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB
Anna C. Need et al.
HUMAN MOLECULAR GENETICS (2009)
A beta-degrading enzymes in Alzheimer's disease
James Scott Miners et al.
BRAIN PATHOLOGY (2008)
The role of junctional adhesion molecules in vascular inflammation
Christian Weber et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation
MG Medina et al.
EMBO JOURNAL (2005)
Robo1 and Robo2 are homophilic binding molecules that promote axonal growth
B Hivert et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2002)
Urokinase-type plasminogen activator inhibits amyloid-β neurotoxicity and fibrillogenesis via plasminogen
HM Tucker et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Junctional adhesion molecule-2 (JAM-2) promotes lymphocyte transendothelial migration
CA Johnson-Léger et al.
BLOOD (2002)
Aβ 17-42 in Alzheimer's disease activates JNK and caspase-8 leading to neuronal apoptosis
WL Wei et al.
BRAIN (2002)
Activation of caspase-8 in the Alzheimer's disease brain
TT Rohn et al.
NEUROBIOLOGY OF DISEASE (2001)
Share Paper
